15-Year watch begins for myeloma patients treated with experimental cell therapy
NCT ID NCT03741127
First seen Mar 10, 2026 · Last updated May 25, 2026 · Updated 11 times
Summary
This long-term follow-up study tracks about 100 people with multiple myeloma who previously received the experimental cell therapy P-BCMA-101. The goal is to check for delayed side effects and see how well the treatment controls the cancer over up to 15 years. Participants are monitored through regular check-ups, and a drug called rimiducid may be given if needed.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE MYELOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Colorado Blood Cancer Institute
Denver, Colorado, 80218, United States
-
Johns Hopkins University
Baltimore, Maryland, 21205, United States
-
MD Anderson Cancer Center
Houston, Texas, 77030, United States
-
Sarah Cannon Research Institute at Tennessee Oncology
Nashville, Tennessee, 37203, United States
-
University of California Davis
Davis, California, 95618, United States
-
University of California San Francisco
San Francisco, California, 94143, United States
-
University of California, San Diego
San Diego, California, 92121, United States
-
University of Chicago
Chicago, Illinois, 60637, United States
-
University of Kansas Cancer Center
Westwood, Kansas, 66205, United States
-
University of Maryland Greenebaum Comprehensive Cancer Center
Baltimore, Maryland, 21201, United States
-
University of Pennsylvania
Philadelphia, Pennsylvania, 19104, United States
-
Vanderbilt University Medical Center
Nashville, Tennessee, 37203, United States
-
Wayne State - Karmanos Cancer Institute
Detroit, Michigan, 48201, United States
Conditions
Explore the condition pages connected to this study.